Antulov R, Weinstock-Guttman B, Cox J, Hussein S, Durfee J, Caiola C, Dwyer M, Bergsland N, Abdelrahman N, Stosic M, Hojnacki D, Munschauer F, Miletic D, Zivadinov R (2009) Gender-related differences in MS: a study of conventional and nonconventional MRI measures. Mult Scler 15:345–354. https://doi.org/10.1177/1352458508099479
CAS
Article
PubMed
Google Scholar
Barnett MH, Prineas JW (2004) Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann Neurol 55:458–468. https://doi.org/10.1002/ana.20016
Article
PubMed
Google Scholar
Benoit C (2017) Enlargement of white matter MS lesions is associated with lesional…. ECTRIMS Online Library. Benoit C. Oct 25 2017; 202400. http://onlinelibrary.ectrims-congress.eu/ectrims/2017/ACTRIMS-ECTRIMS2017/202400/charline.benoit.enlargement.of.white.matter.ms.lesions.is.associated.with.html. Accessed 28 Nov 2017
Bo L, Geurts JJG, Mork SJ, Valk P (2006) Grey matter pathology in multiple sclerosis. Acta Neurol Scand 113:48–50. https://doi.org/10.1111/j.1600-0404.2006.00615.x
Article
Google Scholar
Boven LA, Van Meurs M, Van Zwam M, Wierenga-Wolf A, Hintzen RQ, Boot RG, Aerts JM, Amor S, Nieuwenhuis EE, Laman JD (2006) Myelin-laden macrophages are anti-inflammatory, consistent with foam cells in multiple sclerosis. Brain 129:517–526. https://doi.org/10.1093/brain/awh707
Article
PubMed
Google Scholar
Breij ECW, Brink BP, Veerhuis R, Van Den Berg C, Vloet R, Yan R, Dijkstra CD, Van Der Valk P, Bö L (2008) Homogeneity of active demyelinating lesions in established multiple sclerosis. Ann Neurol 63:16–25. https://doi.org/10.1002/ana.21311
CAS
Article
PubMed
Google Scholar
Brex PA, Ciccarelli O, O’Riordan JI, Sailer M, Thompson AJ, Miller DH (2002) A longitudinal study of abnormalities on MRI and disability from multiple sclerosis. N Engl J Med 346:158–164. https://doi.org/10.1056/NEJMoa011341
Article
PubMed
Google Scholar
Dal-Bianco A, Grabner G, Kronnerwetter C, Weber M, Höftberger R, Berger T, Auff E, Leutmezer F, Trattnig S, Lassmann H, Bagnato F, Hametner S (2017) Slow expansion of multiple sclerosis iron rim lesions: pathology and 7 T magnetic resonance imaging. Acta Neuropathol 133:25–42. https://doi.org/10.1007/s00401-016-1636-z
CAS
Article
PubMed
Google Scholar
Dziedzic T, Metz I, Dallenga T, König FB, Müller S, Stadelmann C, Brück W (2010) Wallerian degeneration: a major component of early axonal pathology in multiple sclerosis. Brain Pathol 20:976–985. https://doi.org/10.1111/j.1750-3639.2010.00401.x
PubMed
Google Scholar
Elliott C (2017) Detection and characterisation of slowly evolving lesions in…. ECTRIMS Online Library. 202544. https://onlinelibrary.ectrims-congress.eu/ectrims/2017/ACTRIMS-ECTRIMS2017/202544/colm.elliott.detection.and.characterisation.of.slowly.evolving.lesions.in.html. Accessed 28 Nov 2017
Fisniku LK, Brex PA, Altmann DR, Miszkiel KA, Benton CE, Lanyon R, Thompson AJ, Miller DH (2008) Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis. Brain 131:808–817. https://doi.org/10.1093/brain/awm329
CAS
Article
PubMed
Google Scholar
Frischer JM, Bramow S, Dal-Bianco A, Lucchinetti CF, Rauschka H, Schmidbauer M, Laursen H, Sorensen PS, Lassmann H (2009) The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain 132:1175–1189. https://doi.org/10.1093/brain/awp070
Article
PubMed
PubMed Central
Google Scholar
Frischer JM, Weigand SD, Guo Y, Kale N, Parisi JE, Pirko I, Mandrekar J, Bramow S, Metz I, Brück W, Lassmann H, Lucchinetti CF (2015) Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque. Ann Neurol 78:710–721. https://doi.org/10.1002/ana.24497
Article
PubMed
PubMed Central
Google Scholar
Graeber MB, Bise K, Mehraein P (1994) CR3/43, a marker for activated human microglia: application to diagnostic neuropathology. Neuropathol Appl Neurobiol 20:406–408
CAS
Article
PubMed
Google Scholar
De Groot CJ, Bergers E, Kamphorst W, Ravid R, Polman CH, Barkhof F, van der Valk P (2001) Post-mortem MRI-guided sampling of multiple sclerosis brain lesions: increased yield of active demyelinating and (p)reactive lesions. Brain 124:1635–1645
Article
PubMed
Google Scholar
Haider L, Zrzavy T, Hametner S, Höftberger R, Bagnato F, Grabner G, Trattnig S, Pfeifenbring S, Brück W, Lassmann H (2016) The topography of demyelination and neurodegeneration in the multiple sclerosis brain. Brain 139:807–815. https://doi.org/10.1093/brain/awv398
Article
PubMed
PubMed Central
Google Scholar
Harrison DM, Li X, Liu H, Jones CK, Caffo B, Calabresi PA, Van Zijl P (2016) Lesion heterogeneity on high-field susceptibility MRI Is associated with multiple sclerosis severity. Am J Neuroradiol 37:1447–1453. https://doi.org/10.3174/ajnr.A4726
CAS
Article
PubMed
PubMed Central
Google Scholar
Hegen H, Auer M, Deisenhammer F (2016) Predictors of response to multiple sclerosis therapeutics in individual patients. Drugs 76:1421–1445. https://doi.org/10.1007/s40265-016-0639-3
CAS
Article
PubMed
Google Scholar
Hendrickx DAE, van Eden CG, Schuurman KG, Hamann J, Huitinga I (2017) Staining of HLA-DR, Iba1 and CD68 in human microglia reveals partially overlapping expression depending on cellular morphology and pathology. J Neuroimmunol 309:12–22. https://doi.org/10.1016/j.jneuroim.2017.04.007
CAS
Article
PubMed
Google Scholar
Hendrickx DAE, Koning N, Schuurman KG, van Strien ME, van Eden CG, Hamann J, Huitinga I (2013) Selective upregulation of scavenger receptors in and around demyelinating areas in multiple sclerosis. J Neuropathol Exp Neurol 72:106–118. https://doi.org/10.1097/NEN.0b013e31827fd9e8
CAS
Article
PubMed
Google Scholar
Herranz E, Giannì C, Louapre C, Treaba CA, Govindarajan ST, Ouellette R, Loggia ML, Sloane JA, Madigan N, Izquierdo-Garcia D, Ward N, Mangeat G, Granberg T, Klawiter EC, Catana C, Hooker JM, Taylor N, Ionete C, Kinkel RP, Mainero C (2016) Neuroinflammatory component of gray matter pathology in multiple sclerosis. Ann Neurol 80:776–790. https://doi.org/10.1002/ana.24791
CAS
Article
PubMed
PubMed Central
Google Scholar
van Horssen J, Singh S, van der Pol S, Kipp M, Lim JL, Peferoen L, Gerritsen W, Kooi E-J, Witte ME, Geurts JJ, de Vries HE, Peferoen-Baert R, van den Elsen PJ, van der Valk P, Amor S (2012) Clusters of activated microglia in normal-appearing white matter show signs of innate immune activation. J Neuroinflamm 9:602. https://doi.org/10.1186/1742-2094-9-156
Article
Google Scholar
Koch-Henriksen N, Sørensen PS (2010) The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol 9:520–532. https://doi.org/10.1016/S1474-4422(10)70064-8
Article
PubMed
Google Scholar
Kuhlmann T, Lassmann H, Brück W (2008) Diagnosis of inflammatory demyelination in biopsy specimens: a practical approach. Acta Neuropathol 115:275–287. https://doi.org/10.1007/s00401-007-0320-8
Article
PubMed
PubMed Central
Google Scholar
Kuhlmann T, Ludwin S, Prat A, Antel J, Brück W, Lassmann H (2017) An updated histological classification system for multiple sclerosis lesions. Acta Neuropathol 133:13–24. https://doi.org/10.1007/s00401-016-1653-y
CAS
Article
PubMed
Google Scholar
Lagumersindez-Denis N, Wrzos C, Mack M, Winkler A, van der Meer F, Reinert MC, Hollasch H, Flach A, Brühl H, Cullen E, Schlumbohm C, Fuchs E, Linington C, Barrantes-Freer A, Metz I, Wegner C, Liebetanz D, Prinz M, Brück W, Stadelmann C, Nessler S (2017) Differential contribution of immune effector mechanisms to cortical demyelination in multiple sclerosis. Acta Neuropathol. https://doi.org/10.1007/s00401-017-1706-x
PubMed
PubMed Central
Google Scholar
Lassmann H, Raine CS, Antel J, Prineas JW (1998) Immunopathology of multiple sclerosis: report on an international meeting held at the Institute of Neurology of the University of Vienna. J Neuroimmunol 86:213–217. https://doi.org/10.1016/S0165-5728(98)00031-9
CAS
Article
PubMed
Google Scholar
Leray E, Yaouanq J, Le Page E, Coustans M, Laplaud D, Oger J, Edan G (2010) Evidence for a two-stage disability progression in multiple sclerosis. Brain 133:1900–1913. https://doi.org/10.1093/brain/awq076
Article
PubMed
PubMed Central
Google Scholar
Levtova N, Healy LM, Marysol C, Gonczi C, Stopnicki B, Blain M, Kennedy TE, Moore CS, Antel JP, Darlington PJ (2017) Comparative morphology and phagocytic capacity of primary human adult microglia with time-lapse imaging. J Neuroimmunol 310:143–149. https://doi.org/10.1016/j.jneuroim.2017.05.012
CAS
Article
PubMed
Google Scholar
van der Loos CM (2008) Multiple immunoenzyme staining: methods and visualizations for the observation with spectral imaging. J Histochem Cytochem 56:313–328. https://doi.org/10.1369/jhc.2007.950170
Article
PubMed
PubMed Central
Google Scholar
Lublin FD, Reingold SC (1996) Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) advisory committee on clinical trials of new agents in multiple sclerosis. Neurology 46:907–911
CAS
Article
PubMed
Google Scholar
Lublin FD, Reingold SC, Cohen JA, Cutter GR, Sørensen PS, Thompson AJ, Wolinsky JS, Balcer LJ, Banwell B, Barkhof F, Bebo B, Calabresi PA, Clanet M, Comi G, Fox RJ, Freedman MS, Goodman AD, Inglese M, Kappos L, Kieseier BC, Lincoln JA, Lubetzki C, Miller AE, Montalban X, O’Connor PW, Petkau J, Pozzilli C, Rudick RA, Sormani MP, Stüve O, Waubant E, Polman CH, Polman CH (2014) Defining the clinical course of multiple sclerosis: the 2013 revisions. Neurology 83:278–286. https://doi.org/10.1212/WNL.0000000000000560
Article
PubMed
PubMed Central
Google Scholar
Lucchinetti C, Brück W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H (2000) Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination. Ann Neurol 47:707–717. https://doi.org/10.1002/1531-8249(200006)47:6<707::aid-ana3>3.0.co;2-q
Luchetti S, van Eden CG, Schuurman K, van Strien ME, Swaab DF, Huitinga I (2014) Gender differences in multiple sclerosis. J Neuropathol Exp Neurol 73:123–135. https://doi.org/10.1097/NEN.0000000000000037
CAS
Article
PubMed
Google Scholar
Magliozzi R, Howell O, Vora A, Serafini B, Nicholas R, Puopolo M, Reynolds R, Aloisi F (2007) Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain 130:1089–1104. https://doi.org/10.1093/brain/awm038
Article
PubMed
Google Scholar
Metz I, Weigand SD, Popescu BFG, Frischer JM, Parisi JE, Guo Y, Lassmann H, Brück W, Lucchinetti CF (2014) Pathologic heterogeneity persists in early active multiple sclerosis lesions. Ann Neurol 75:728–738. https://doi.org/10.1002/ana.24163
Article
PubMed
PubMed Central
Google Scholar
Michailidou I, Naessens DMP, Hametner S, Guldenaar W, Kooi E-J, Geurts JJG, Baas F, Lassmann H, Ramaglia V (2017) Complement C3 on microglial clusters in multiple sclerosis occur in chronic but not acute disease: implication for disease pathogenesis. Glia 65:264–277. https://doi.org/10.1002/glia.23090
Article
PubMed
Google Scholar
Patrikios P, Stadelmann C, Kutzelnigg A, Rauschka H, Schmidbauer M, Laursen H, Sorensen PS, Brück W, Lucchinetti C, Lassmann H (2006) Remyelination is extensive in a subset of multiple sclerosis patients. Brain 129:3165–3172. https://doi.org/10.1093/brain/awl217
Article
PubMed
Google Scholar
Prineas JW (1979) Multiple sclerosis: presence of lymphatic capillaries and lymphoid tissue in the brain and spinal cord. Science 203:1123–1125
CAS
Article
PubMed
Google Scholar
Simpson J, Rezaie P, Newcombe J, Cuzner ML, Male D, Woodroofe MN (2000) Expression of the beta-chemokine receptors CCR2, CCR3 and CCR5 in multiple sclerosis central nervous system tissue. J Neuroimmunol 108:192–200
CAS
Article
PubMed
Google Scholar
Singh S, Metz I, Amor S, Van Der Valk P, Stadelmann C, Brück W (2013) Microglial nodules in early multiple sclerosis white matter are associated with degenerating axons. Acta Neuropathol 125:595–608. https://doi.org/10.1007/s00401-013-1082-0
CAS
Article
PubMed
PubMed Central
Google Scholar
Tourbah A, Stievenart JL, Abanou A, Fontaine B, Cabanis EA, Lyon-Caen O (2001) Correlating multiple MRI parameters with clinical features: an attempt to define a new strategy in multiple sclerosis. Neuroradiology 43:712–720
CAS
Article
PubMed
Google Scholar
van der Valk P, Amor S (2009) Preactive lesions in multiple sclerosis. Curr Opin Neurol. https://doi.org/10.1097/WCO.0b013e32832b4c76
PubMed
Google Scholar
Van Der Valk P, De Groot CJA (2000) Staging of multiple sclerosis (MS) lesions: pathology of the time frame of MS. Neuropathol Appl Neurobiol 26:2–10. https://doi.org/10.1046/j.1365-2990.2000.00217.x
Article
PubMed
Google Scholar